Postby rp1954 » Sat Sep 26, 2015 11:55 am
Sounds like your dr has already checked out, I'd be shopping and interviewing. "... can [they] take quicker actions?" Yes - the real question is can you - we always have to advocate for ourselves.
Blood tests may not catch everything but the current "standards" (NCCN, ASCO, etc) are not well designed to protect attentive stage 4s in the zone between first NED and five years out. A CEA test is not very thorough coverage nor is even quarterly likely to be timely for a fast developing problem. Scheduled scan images are usually quarters behind what is possible with frequent biomarkers, trended. A large percent will recur sometime, and need timely treatment to either resolve it, while curative surgery is possible, or to yield the maximum chances and time. Biological and chemical tweaking also becomes possible.
Suppose you knew for absolute sure that you would recur at some random time in those 3-4 years, as most still do. What could you do? What would you do if you were a multimillionaire with a finger prick cancer test?
Multiple kinds of markers, blood taken and results accumulated weekly, reviewed bi/monthly by an expert analyst would be pretty protective. Few of the "oh-my-god" surprises we see and there would be better options. The limitations are the tests themselves, the physical limitations of sampling, personal psychology, economics and the expertise.
In the near future, it may be possible to drop by Walgreenmart, and get your finger/elbow stuck for a few drops and get 10-20 panels. I'd be willing to do that weekly, maybe 10 days, and have it automatically swept into my spreadsheet. Even now, with the current sanguineous blood draws and a budget, we've found 2-6 weeks doable. Second, is that most people have a lot of scatter in their data due to inflammation, (cancer) metabolism or lab test methods. This scatter can reduced and minimized in the NED period and with some treatments, but is a medically unaddressed/underserved area.
Psychologically, it would be best if the patient didn't have to see every high frequency test asap, but rather had a brief consult monthly, bimonthly or even quarterly that scored or reviewed a matrix of several accumulated tests that yielded more graded information and certainty, and some minor chemical recommendations.
Finally, the big sticker is expertise. Some medical papers are slowly admiting that various biomarker trends are very sensitive and predictive, useful in practice. Multiple markers in skillful combination is even further behind. However our doctors mostly seem to be ignorant or asleep on these subjects, and the national payers, HMOs, insurance companies or their stooge doctors would probably attack them if they weren't. We probably need a results oriented (inter)national colorectal subscriber service to do this.
Even today, given the costs of belated treatment, the economics should not be a barrier for monthly draws. Our system is just not arranged efficently and effectively for us.
FYI, we watch for problems, including liver, with CEA, (AFP or CA19-9, one frequent, one qtrly), ALP, GGT, LDH, adjusted and quality controlled with hsCRP and ESR, "monthly" (4-6 wks) in good times. If we had LEF prices available, we'd do quantitative D-dimer more often, at 4-9 week intervals.
watchful, active researcher and caregiver for stage IVb/c CC. surgeries 4/10 sigmoid etc & 5/11 para-aortic LN cluster; 8 yrs immuno-Chemo for mCRC; now no chemo
most of 2010 Life Extension recommendations and possibilities + more, some (much) higher, peaking ~2011-12, taper chemo to almost nothing mid 2018, IV C-->2021. Now supplements